Streetbeat News

ALUR

Allurion Technologies Inc.

https://www.allurion.com

Industry

Medical - Devices

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Open

0.35

Mkt cap

22M

Volume

472K

High

0.35

P/E Ratio

-0.82

52-wk high

4.00

Low

0.32

Div yield

N/A

52-wk low

0.31

Allurion Technologies Inc. (ALUR) held its Q3 2024 earnings call, discussing company performance and future outlook.

Portfolio Pulse from

November 13, 2024 | 6:00 pm

Allurion Technologies has submitted the first three modules of its Premarket Approval (PMA) application to the FDA for the Allurion Balloon, a weight loss device. This marks a significant step in the regulatory process for the company.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:02 pm

The article reports on the after-market movements of several consumer discretionary stocks. Notable gainers include Cheetah Net Supply Chain, Connexa Sports Techs, and Autozi Internet Tech, while Digital Brands Group, Vision Marine, and Designer Brands were among the losers.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 8:31 pm

In Monday's after-market session, several consumer discretionary stocks experienced significant movements. Ambow Education Holding (AMEX:AMBO) led the gainers with a 29.4% increase, while Digital Brands Group (NASDAQ:DBGI) saw the largest decline, falling 25.1%.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 8:31 pm

The article highlights the intraday movements of consumer discretionary stocks on Wednesday. Notable gainers include Kaixin Holdings, Color Star Tech, and QuantaSing Group, while significant losers include Golden Sun Health, Jowell Global, and Uxin.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 4:31 pm

In Wednesday's pre-market session, several consumer discretionary stocks experienced significant movements. Kaixin Holdings (KXIN) saw an 80.2% increase, while Nike (NKE) fell by 7.7% following its Q1 earnings report. Other notable gainers include QuantaSing Group (QSG) and Allurion Technologies (ALUR), while Kidpik (PIK) and Twin Vee PowerCats (VEEE) were among the losers.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 12:06 pm

Allurion Technologies shares rose after TD Cowen initiated coverage with a Buy rating and set a $2 price target.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:56 am

TD Cowen has initiated coverage on Allurion Technologies with a Buy rating and set a price target of $2. This suggests a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:52 am

Allurion has published a meta-analysis demonstrating an average weight loss of 12.5% and significant metabolic health benefits across 2,107 patients in 11 studies. This could positively impact Allurion's market position and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:11 pm

Roth MKM has initiated coverage on Allurion Technologies with a Buy rating and set a price target of $2.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2024 | 3:59 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.